FOLH1 and neoplasm: In this study, MPA combined with a PSMA tracer, Al18F-PSMA-CM, was proven to have high PSMA specificity, longer half-life in the blood, and high tumor uptake, indicating that the introduction of MPA to PSMA-targeted tracers is a good strategy to extend the half-life of tracers.